These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 24872345

  • 1. Once-daily dosed gentamicin is more nephrotoxic than once-daily dosed tobramycin in clinically infected patients.
    van Maarseveen E, van Buul-Gast MC, Abdoellakhan R, Gelinck L, Neef C, Touw D.
    J Antimicrob Chemother; 2014 Sep; 69(9):2581-3. PubMed ID: 24872345
    [No Abstract] [Full Text] [Related]

  • 2. Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study.
    Kumin GD.
    JAMA; 1980 Oct 17; 244(16):1808-10. PubMed ID: 7420681
    [Abstract] [Full Text] [Related]

  • 3. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE, Mouton JW, Gyssens IC, Verbrugh HA, Bruining HA.
    Intensive Care Med; 2002 Jul 17; 28(7):936-42. PubMed ID: 12122533
    [Abstract] [Full Text] [Related]

  • 4. Controlled comparison of gentamicin and tobramycin nephrotoxicity.
    Matzke GR, Lucarotti RL, Shapiro HS.
    Am J Nephrol; 1983 Jul 17; 3(1):11-7. PubMed ID: 6340504
    [Abstract] [Full Text] [Related]

  • 5. Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs.
    Reiner NE, Bloxham DD, Thompson WL.
    J Antimicrob Chemother; 1978 May 17; 4 Suppl A():85-101. PubMed ID: 659354
    [No Abstract] [Full Text] [Related]

  • 6. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.
    Smith CR, Lipsky JJ, Laskin OL, Hellmann DB, Mellits ED, Longstreth J, Lietman PS.
    N Engl J Med; 1980 May 15; 302(20):1106-9. PubMed ID: 6988713
    [Abstract] [Full Text] [Related]

  • 7. Renal toxicity. Tobramycin and gentamicin.
    Fry TL, Fried FA, Goven BA.
    Invest Urol; 1977 Sep 15; 15(2):100-3. PubMed ID: 903207
    [Abstract] [Full Text] [Related]

  • 8. [Nephrotoxicity of gentamycin and tobramycin combined with methicillin or cephalothin].
    Lietman PS.
    Nouv Presse Med; 1978 Nov 29; 7(42):3833-4. PubMed ID: 714687
    [No Abstract] [Full Text] [Related]

  • 9. Minimizing the toxicity of aminoglycosides in cystic fibrosis.
    Smyth AR.
    J R Soc Med; 2010 Jul 29; 103 Suppl 1(Suppl 1):S3-5. PubMed ID: 20573667
    [No Abstract] [Full Text] [Related]

  • 10. Long-term effect of chronic intravenous and inhaled nephrotoxic antibiotic treatment on the renal function of patients with cystic fibrosis.
    Florescu MC, Lyden E, Murphy PJ, Florescu DF, Fillaus J.
    Hemodial Int; 2012 Jul 29; 16(3):414-9. PubMed ID: 22469183
    [Abstract] [Full Text] [Related]

  • 11. Once-daily gentamicin in infants and children: a prospective cohort study evaluating safety and the role of therapeutic drug monitoring in minimizing toxicity.
    Best EJ, Gazarian M, Cohn R, Wilkinson M, Palasanthiran P.
    Pediatr Infect Dis J; 2011 Oct 29; 30(10):827-32. PubMed ID: 21577177
    [Abstract] [Full Text] [Related]

  • 12. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy.
    Prins JM, Weverling GJ, de Blok K, van Ketel RJ, Speelman P.
    Antimicrob Agents Chemother; 1996 Nov 29; 40(11):2494-9. PubMed ID: 8913452
    [Abstract] [Full Text] [Related]

  • 13. Short-term gentamicin therapy and risk of renal toxicity in patients with bacteraemia.
    Spanggaard MH, Hønge BL, Schønheyder HC, Nielsen H.
    Scand J Infect Dis; 2011 Dec 29; 43(11-12):953-6. PubMed ID: 21867467
    [Abstract] [Full Text] [Related]

  • 14. Aminoglycoside-induced reversible tubular dysfunction.
    Alexandridis G, Liberopoulos E, Elisaf M.
    Pharmacology; 2003 Mar 29; 67(3):118-20. PubMed ID: 12571406
    [Abstract] [Full Text] [Related]

  • 15. Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients.
    Prins JM, Weverling GJ, van Ketel RJ, Speelman P.
    Clin Pharmacol Ther; 1997 Jul 29; 62(1):106-11. PubMed ID: 9246024
    [Abstract] [Full Text] [Related]

  • 16. Acute Kidney Injury With Tobramycin-Impregnated Bone Cement Spacers in Prosthetic Joint Infections.
    Aeng ES, Shalansky KF, Lau TT, Zalunardo N, Li G, Bowie WR, Duncan CP.
    Ann Pharmacother; 2015 Nov 29; 49(11):1207-13. PubMed ID: 26269097
    [Abstract] [Full Text] [Related]

  • 17. Acute renal failure after local gentamicin treatment in an infected total knee arthroplasty.
    van Raaij TM, Visser LE, Vulto AG, Verhaar JA.
    J Arthroplasty; 2002 Oct 29; 17(7):948-50. PubMed ID: 12375257
    [Abstract] [Full Text] [Related]

  • 18. [Use of acrylic cement with antibiotic in primary arthroplasty].
    Langlais F, Judet H, Vielpeau C, Bernard L, Chauveaux D, Beaufils P, Bernard L, Dujardin F, Hamadouche M, Mamoudy P, Migaud H, Minet J, Pégoix M, Senneville E, Tabutin J, Bonnomet F, Caillon J, Potel G, Rosencher N, Samama CM.
    Rev Chir Orthop Reparatrice Appar Mot; 2008 Oct 29; 94 Suppl(6):S215-8. PubMed ID: 18928818
    [No Abstract] [Full Text] [Related]

  • 19. No increased risk of acute kidney injury after a single dose of gentamicin in patients with sepsis.
    Cobussen M, de Kort JM, Dennert RM, Lowe SH, Stassen PM.
    Infect Dis (Lond); 2016 Apr 29; 48(4):274-280. PubMed ID: 26567531
    [Abstract] [Full Text] [Related]

  • 20. Intravenous injection of gentamicin and tobramycin without impairment of hearing.
    Dobbs SM, Mawer GE.
    J Infect Dis; 1976 Aug 29; 134 Suppl():S114-7. PubMed ID: 972268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.